Physician profile
Meredith R Tschoke
NPI 1356852792
$1,925.39
in general payments reported to CMS, 2019-2025
17 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2023: $511 · 2024: $1,415.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,514 · Travel and Lodging: $412.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,513.53 |
| Travel and Lodging | $411.86 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Livanova USA, INC. | $610.60 | 2024 | Vns Therapy |
| Scilex Pharmaceuticals INC. | $338.26 | 2023-2024 | Ztlido |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $166.68 | 2023-2024 | Relistor |
| Collegium Pharmaceutical, INC. | $165.36 | 2023-2024 | Belbuca, Xtampza |
| Abbvie INC. | $126.26 | 2023-2024 | |
| Valinor Pharma, LLC | $83.64 | 2023-2024 | Movantik |
| Forte Bio-Pharma LLC | $73.14 | 2023 | Prolate, Nalocet |
| Novartis Pharmaceuticals Corporation | $64.65 | 2023-2024 | |
| Nevro Corp. | $52.78 | 2024 | Senza |
| Lilly USA, LLC | $49.17 | 2023-2024 | Emgality, Reyvow |
| Inspire Medical Systems, INC. | $43.51 | 2023-2024 | Inspire |
| Averitas Pharma INC. | $31.27 | 2024 | Qutenza |
| Sk Life Science, INC. | $29.67 | 2023 | |
| Ucb, INC. | $27.92 | 2024 | Briviact |
| Axsome Therapeutics, INC. | $24.33 | 2023 | Sunosi |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Jazz Pharmaceuticals INC. | $21.56 | 2023 | |
| Pfizer INC. | $16.59 | 2023 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Meredith Tschoke listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.